{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Sunshine Biopharma Inc."},"Symbol":{"label":"Symbol","value":"SBFMW"},"Address":{"label":"Address","value":"6500 TRANS-CANADA HIGHWAY,4TH FLOOR, POINTE-CLAIRE, Quebec, H9R 0A5, Canada"},"Phone":{"label":"Phone","value":"+1 514 426-6161"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5)."},"CompanyUrl":{"label":"Company Url","value":"https://www.sunshinebiopharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Abderrazzak Merzouki","title":"Chief Science Officer & Director"},{"name":"Steve N. Slilaty","title":"Chairman, President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}